Broadcom Locks Apple Through 2031, AVGO Outperforms
Broadcom inks a long-term extension with Apple through 2031, tying roughly 20% of AVGO's annual sales to the iPhone m...
Stay updated with the latest weekly cash back credit card deals to maximize your savings. Don't miss these offers!
23,042 articlesBroadcom inks a long-term extension with Apple through 2031, tying roughly 20% of AVGO's annual sales to the iPhone m...
Nvidia surged into the spotlight as a long-term wealth engine for many investors. This guide asks the hard question: ...
As physical toll climbs for seasoned tradespeople, more are weighing claiming Social Security early. Industry forecas...
A new mega-listing grabbed headlines by raising $26.5 billion, ranking just below SpaceX in U.S. market history. Read...
A high-profile moment can teach practical money lessons. Discover how to translate celebrity vibes into smarter budge...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
When a notable manager trims a stake in a popular ETF, it can offer clues about risk, opportunity, and the broader ma...
This piece examines which stocks people actually search for and why those trends matter. Learn how to separate curios...
Boeing’s stock is drawing fresh attention as defense-focused equities outperform, underpinned by a robust backlog and...
A notable stake by 140 Summer Partners LP in Acuity Brands is turning heads in the investing world. This article brea...
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
In 2026, two names inside the Magnificent Seven could deliver outsized AI gains that fly under the radar. This guide ...